Astellas Pharma Inc
Astellas Pharma's GHG Emissions Data Preview
In 2023, Astellas Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Astellas Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
b
b
b
b
b
b
b
bCreate your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.
Verified Sources Behind Astellas Pharma’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Astellas Pharma’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
Insights into Astellas Pharma's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Astellas Pharma amounted to 122,250 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Astellas Pharma increased by 3.92%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
Astellas Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Astellas Pharma's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Astellas Pharma were 59,203 metric tons of CO₂ equivalent (tCO₂e). a
Has Astellas Pharma reduced its Scope 1 emissions over time?
Since 2019, Astellas Pharma's Scope 1 emissions have decreased by 16.5%, reflecting a declining long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2022), Astellas Pharma's Scope 1 emissions decreased by 3.22%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
What are Astellas Pharma's Scope 2 emissions?
In 2023, Astellas Pharma reported Scope 2 greenhouse gas (GHG) emissions of 63,047 tCO₂e using the market-based method. a
Has Astellas Pharma reduced its Scope 2 emissions over time?
Since 2019, Astellas Pharma's Scope 2 greenhouse gas (GHG) emissions (Market-Based) have decreased by 33.8%, reflecting a declining long-term trend in Scope 2 emissions over time. a b
Compared to the previous year (2022), Astellas Pharma's Scope 2 emissions (Market-Based) rose by 11.64% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a
What methodology does Astellas Pharma use for Scope 2 reporting?
In 2023, Astellas Pharma reported its Scope 2 emissions using the market-based method. a
Astellas Pharma's Scope 2 Emissions Over Time
- Total Scope 2 Market-Based